Abstract
The miniaturization of potentiometric sensors is developing only slowly. ISFET technology has not yet brought great breakthroughs in this respect. Potentiometric microelectrode arrays are developed however for DNA analysis. As potentiometry moves into new and unexpected applications such as biomolecules, multiply charged molecules, DNA, marker proteins, viruses and bacteria, dissolution testing..., the need for miniaturized sensors and arrays will grow. Possibly, planar screen printed electrodes can be applied. Use of the electrodes in hydrodynamic conditions may be needed. The use of FIA and HPLC for rapid screening of electrode compositions is explained. This provides new insights into these chemically dynamic sensor systems, and into the interaction of organic ionic molecules with surfaces.
Current Pharmaceutical Analysis
Title: Potentiometric Sensors for Organic Analytes: Insights to Proceed to Miniaturization
Volume: 5 Issue: 2
Author(s): Luc J. Nagels, Bert Vissers, Hugo Bohets, Joseph Everaert and Johan Robbens
Affiliation:
Abstract: The miniaturization of potentiometric sensors is developing only slowly. ISFET technology has not yet brought great breakthroughs in this respect. Potentiometric microelectrode arrays are developed however for DNA analysis. As potentiometry moves into new and unexpected applications such as biomolecules, multiply charged molecules, DNA, marker proteins, viruses and bacteria, dissolution testing..., the need for miniaturized sensors and arrays will grow. Possibly, planar screen printed electrodes can be applied. Use of the electrodes in hydrodynamic conditions may be needed. The use of FIA and HPLC for rapid screening of electrode compositions is explained. This provides new insights into these chemically dynamic sensor systems, and into the interaction of organic ionic molecules with surfaces.
Export Options
About this article
Cite this article as:
Nagels J. Luc, Vissers Bert, Bohets Hugo, Everaert Joseph and Robbens Johan, Potentiometric Sensors for Organic Analytes: Insights to Proceed to Miniaturization, Current Pharmaceutical Analysis 2009; 5 (2) . https://dx.doi.org/10.2174/157341209788172898
DOI https://dx.doi.org/10.2174/157341209788172898 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cytokines in HIV-Infection - Inflammatory Damage or Therapeutic Potential?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Non-Replicating Viral Vector-Based AIDS Vaccines: Interplay Between Viral Vectors and the Immune System
Current HIV Research Methamphetamine and HIV Infection, Role in Neurocognitive Dysfunction
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target
Current Medicinal Chemistry True or False? Activations of Language-related Areas in Patients with Disorders of Consciousness
Current Pharmaceutical Design Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design Global Warming Favors Pathogenicity of the Brain-Eating Amoebae
Anti-Infective Agents Reverse Vaccinology: An Epitope Based Approach to Design Vaccines
Current Bioinformatics Purine Molecules as Hypnogenic Factors Role of Adenosine, ATP, and Caffeine
Central Nervous System Agents in Medicinal Chemistry Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
Current Alzheimer Research Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing
Current Gene Therapy Experimental Strategies in Autoimmunity: Antagonists of Cytokines and their Receptors, Nanocarriers, Inhibitors of Immunoproteasome, Leukocyte Migration and Protein Kinases
Current Pharmaceutical Design Recent Patents on the Baculovirus Systems
Recent Patents on Biotechnology Inactivated- or Killed-Virus HIV/AIDS Vaccines
Current Drug Targets - Infectious Disorders Exosomes and the Emerging Field of Exosome-Based Gene Therapy
Current Gene Therapy Biology of Mesenchymal Stem Cells
Current Rheumatology Reviews Catatonia Due to a General Medical Condition (Organic Catatonia)
Current Psychiatry Reviews Recombinant Rhabdoviruses as Potential Vaccines for HIV-1 and Other Diseases
Current HIV Research